fluoxetine has been researched along with Atherogenesis in 3 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatments (fluoxetine 10 mg/kg; NaCl 0." | 1.38 | Fluoxetine effect on aortic nitric oxide-dependent vasorelaxation in the unpredictable chronic mild stress model of depression in mice. ( Belzung, C; Camus, V; Freslon, JL; Isingrini, E; Machet, MC, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rami, M | 1 |
| Guillamat-Prats, R | 1 |
| Rinne, P | 1 |
| Salvermoser, M | 1 |
| Ring, L | 1 |
| Bianchini, M | 1 |
| Blanchet, X | 1 |
| Megens, RTA | 1 |
| Döring, Y | 1 |
| Walzog, B | 1 |
| Soehnlein, O | 1 |
| Weber, C | 1 |
| Faussner, A | 1 |
| Steffens, S | 1 |
| Wang, J | 1 |
| Eitzman, DT | 1 |
| Isingrini, E | 1 |
| Belzung, C | 1 |
| Freslon, JL | 1 |
| Machet, MC | 1 |
| Camus, V | 1 |
3 other studies available for fluoxetine and Atherogenesis
| Article | Year |
|---|---|
Chronic Intake of the Selective Serotonin Reuptake Inhibitor Fluoxetine Enhances Atherosclerosis.
Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Blood Platelets; Capillary Permeability; Carotid A | 2018 |
Do Selective Serotonin Reuptake Inhibitor Antidepressant Drugs Promote Atherosclerosis?
Topics: Antidepressive Agents; Atherosclerosis; Depression; Fluoxetine; Humans; Selective Serotonin Reuptake | 2018 |
Fluoxetine effect on aortic nitric oxide-dependent vasorelaxation in the unpredictable chronic mild stress model of depression in mice.
Topics: Acetylcholine; Animals; Aorta; Atherosclerosis; Biological Factors; Depressive Disorder, Major; Dise | 2012 |